Takeda to sell Japan consumer health unit valued at $2.3 billion to Blackstone

© Reuters. FILE PHOTO: Takeda Pharmaceutical’s logo is seen at its headquarters in Tokyo By Junko Fujita TOKYO (Reuters) – Takeda Pharmaceutical Co said on Monday it would sell its Japanese consumer healthcare business to U.S. buyout fund Blackstone Group (NYSE:), as it aims to focus on developing drugs for unmet medical needs and rare […]

Continue Reading